Literature DB >> 20025912

Investigation of clinical factors influencing cognitive function in Japanese schizophrenia.

Taro Kishi1, Masatsugu Moriwaki, Kunihiro Kawashima, Tomo Okochi, Yasuhisa Fukuo, Tsuyoshi Kitajima, Osamu Furukawa, Hiroshi Naitoh, Kiyoshi Fujita, Nakao Iwata.   

Abstract

Several investigators have reported cognitive dysfunction in chronic schizophrenia that was associated with insight and social skills. Such cognitive dysfunction seriously hinders an immediate return to normal life. Recently, Kaneda et al. reported that the Brief Assessment of Cognition in Schizophrenia, Japanese-language version (BACS-J) was superior in the evaluation of the cognitive function. We investigated which clinical factors (age, sex, duration of illness, level of education, smoking status, the Positive and Negative Syndrome Scale (PANSS) score and medication dosage) affected cognitive dysfunction in 115 Japanese schizophrenic patients, with the use of multiple regression analysis. We detected an association between composite score, verbal memory, working memory and executive function and PANSS total score. Moreover, most cognitive tasks were associated with a negative PANSS score but not a positive PANSS score or general score. We also showed an association between age and verbal fluency and attention in schizophrenia. In addition, anxiolytics/hypnotics (diazepam-equivalent) were associated with composite score, working memory and motor speed. In conclusion, cognitive function was associated with PANSS score, especially negative PANSS score. Because anxiolytics/hypnotics might have a detrimental influence on cognitive function, we strongly suggest that the use of anxiolytics/hypnotics be reduced in schizophrenics as much as possible. Crown Copyright 2009. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20025912     DOI: 10.1016/j.neures.2009.12.007

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  10 in total

1.  Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.

Authors:  Guillaume Fond; F Berna; L Boyer; O Godin; L Brunel; M Andrianarisoa; B Aouizerate; D Capdevielle; I Chereau; J M Danion; C Dubertret; J Dubreucq; C Faget; F Gabayet; T Le Gloahec; P M Llorca; J Mallet; D Misdrahi; R Rey; R Richieri; C Passerieux; C Portalier; P Roux; A Vehier; H Yazbek; F Schürhoff; E Bulzacka
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-27       Impact factor: 5.270

2.  The relationship between acoustic startle response measures and cognitive functions in Japanese patients with schizophrenia.

Authors:  Taro Kishi; Yasuhisa Fukuo; Tomo Okochi; Kunihiro Kawashima; Masatsugu Moriwaki; Osamu Furukawa; Kiyoshi Fujita; Giovanna M Musso; Christoph U Correll; John M Kane; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2012-03-28       Impact factor: 3.843

3.  The Relationship between Attention/Vigilance and Symptom Severity in Schizophrenic Patients.

Authors:  Atefeh Ghanbari Jolfaei; Pegah Moshki; Mania Asgharpour; Hamid Moshki
Journal:  Iran J Psychiatry       Date:  2012

4.  The interactive effects of stress and coping style on cognitive function in patients with schizophrenia.

Authors:  Xiaodan Zhu; Xuebing Xu; Chao Xu; Jingyi Zhang; Xiaofeng Zhang; Li Ma; Juan Liu; Kefang Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-21       Impact factor: 2.570

5.  Microstructural abnormalities in callosal fibers and their relationship with cognitive function in schizophrenia: A tract-specific analysis study.

Authors:  Yuji Ohoshi; Shun Takahashi; Shinichi Yamada; Takuya Ishida; Kumi Tsuda; Tomikimi Tsuji; Masaki Terada; Kazuhiro Shinosaki; Satoshi Ukai
Journal:  Brain Behav       Date:  2019-07-08       Impact factor: 2.708

6.  Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia.

Authors:  Zhenhe Zhou; Hongmei Zhu; Lin Chen
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

7.  Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia.

Authors:  Ayako Kaneda; Takeshi Katagai; Norio Yasui-Furukori
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-14       Impact factor: 2.570

8.  Association of the Hermansky-Pudlak syndrome type 4 (HPS4) gene variants with cognitive function in patients with schizophrenia and healthy subjects.

Authors:  Go Kuratomi; Atsushi Saito; Yuji Ozeki; Takashi Watanabe; Kumiko Fujii; Kazutaka Shimoda; Toshihiko Inukai; Harunobu Mori; Kenichi Ohmori; Kazufumi Akiyama
Journal:  BMC Psychiatry       Date:  2013-10-30       Impact factor: 3.630

Review 9.  Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper.

Authors:  Arão Nogueira de Araújo; Marion Alves do Nascimento; Eduardo Pondé de Sena; Abrahão Fontes Baptista
Journal:  Drug Healthc Patient Saf       Date:  2014-03-10

10.  Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia.

Authors:  Liang-Jen Wang; Pao-Yen Lin; Yu Lee; Yu-Chi Huang; Su-Ting Hsu; Chi-Fa Hung; Chih-Ken Chen; Yi-Chih Chen; Ya-Ling Wang; Ming-Che Tsai
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-31       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.